Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'DOSE CYTOSINE-ARABINOSIDE' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 213 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Burnett, AK
      Treatment of acute myeloid leukaemia in younger patients

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    2. Sievers, EL
      Efficacy and safety of gemtuzumab ozogamicin in patients with CD33-positive acute myeloid leukaemia in first relapse

      EXPERT OPINION ON BIOLOGICAL THERAPY
    3. Vidarsson, B; Abonour, R; Williams, EC; Woodson, RD; Turman, NJ; Kim, K; Mosher, DF; Wiersma, SR; Longo, WL
      Fludarabine and cytarabine as a sequential infusion regimen for treatment of adults with recurrent, refractory or poor prognosis acute leukemia

      LEUKEMIA & LYMPHOMA
    4. Carella, AM; Cascavilla, N; Greco, MM; Melillo, L; Sajeva, MR; Ladogana, S; D'Arena, G; Perla, G; Carotenuto, M
      Treatment of "poor risk" acute myeloid leukemia with fludarabine, cytarabine and G-CSF (FLAG regimen): A single center study

      LEUKEMIA & LYMPHOMA
    5. Bohgaki, T; Notoya, A; Kondo, M; Mukai, M; Kohno, M
      Leukemia cutis in an elderly patient treated with low dose cytosine arabinoside and etoposide

      LEUKEMIA & LYMPHOMA
    6. Hernandez-Boluda, JC; Cervantes, F; Alvarez, A; Costa, D; Montserrat, E
      Single-agent therapy with oral mercaptopurine for nonlymphoid blast crisisof chronic myeloid leukemia

      ANNALS OF HEMATOLOGY
    7. Kern, W; Schleyer, E; Braess, J; Wittmer, E; Ohnesorge, J; Unterhalt, M; Wormann, B; Buchner, T; Hiddemann, W
      Efficacy of fludarabine, intermittent sequential high-dose cytosine arabinoside, and mitoxantrone [FIS-HAM] salvage therapy in highly resistant acuteleukemias

      ANNALS OF HEMATOLOGY
    8. Garcia-Manero, G; Thomas, DA
      Salvage therapy for refractory or relapsed acute lymphocytic leukemia

      HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
    9. van den Berg, H; van der Flier, M; van de Wetering, MD
      Cytarabine-induced aseptic meningitis

      LEUKEMIA
    10. Shanholtz, C
      Acute life-threatening toxicity of cancer treatment

      CRITICAL CARE CLINICS
    11. Sievers, EL; Larson, RA; Stadtmauer, EA; Estey, E; Lowenberg, B; Dombret, H; Karanes, C; Theobald, M; Bennett, JM; Sherman, ML; Berger, MS; Eten, CB; Loken, MR; van Dongen, JJM; Bernstein, ID; Appelbaum, FR
      Efficacy and safety of gemtuzumab ozogamicin in patients with CD33-positive acute myeloid leukemia in first relapse

      JOURNAL OF CLINICAL ONCOLOGY
    12. Uderzo, C; Conter, V; Dini, G; Locatelli, F; Miniero, R; Tamaro, P
      Treatment of childhood acute lymphoblastic leukemia after the first relapse: curative strategies

      HAEMATOLOGICA
    13. Lee, ST; Jang, JH; Suh, HC; Hahn, JS; Ko, YW; Min, YH
      Idarubicin, cytarabine, and topotecan in patients with refractory or relapsed acute myelogenous leukemia and high-risk myelodysplastic syndrome

      AMERICAN JOURNAL OF HEMATOLOGY
    14. Kimby, E; Nygren, P; Glimelius, B
      A systematic overview of chemotherapy effects in acute myeloid leukaemia

      ACTA ONCOLOGICA
    15. Afenya, EK
      Recovery of normal hemopoiesis in disseminated cancer therapy - a model

      MATHEMATICAL BIOSCIENCES
    16. Shi, Z; Azuma, A; Sampath, D; Li, YX; Huang, P; Plunkett, W
      S-phase arrest by nucleoside analogues and abrogation of survival without cell cycle progression by 7-hydroxystaurosporine

      CANCER RESEARCH
    17. Thomas, X; Berhabri, A
      Acute myeloid leukemia in the elderly: a review

      BULLETIN DU CANCER
    18. Chamberlain, MC
      Neoplastic meningitis: a guide to diagnosis and treatment

      CURRENT OPINION IN NEUROLOGY
    19. Williams, JP; Handler, HL
      Antibody-targeted chemotherapy for the treatment of relapsed acute myeloidleukemia

      AMERICAN JOURNAL OF MANAGED CARE
    20. Treish, IM
      Targeting leukemia cells with gemtuzumab ozogamicin

      CANCER PRACTICE
    21. Ferra, C; Berlanga, JJ; Gallardo, D; Ancin, I; Marin, D; Gonzalez, JR; Peris, J; Munoz, J; Sarra, J; Granena, A
      Mitoxantrone, etoposide, carboplatinum and ara-C combination therapy (Meca) in refractory and relapsed acute leukemia

      LEUKEMIA & LYMPHOMA
    22. Giles, FJ; Shan, JQ; Chen, SS; Advani, SH; Supandiman, I; Aziz, Z; Caviles, AP; Tee, GY; Chasen, MR; Fahed, Z; Chao, TY; Aydogdu, I; Lynott, AM
      A prospective randomized study of alpha-2b interferon plus hydroxyurea or cytarabine for patients with early chronic phase chronic myelogenous leukemia: The International Oncology Study Group CML1 study

      LEUKEMIA & LYMPHOMA
    23. Ohno, R
      How high can we increase complete remission rate in adult acute myeloid leukemia?

      INTERNATIONAL JOURNAL OF HEMATOLOGY
    24. Burnett, AK; Kell, J; Rowntree, G
      Role of allogeneic and autologous hematopoietic stem cell transplantation in acute myeloid leukemia

      INTERNATIONAL JOURNAL OF HEMATOLOGY
    25. Buchner, T; Hiddemann, W; Wormann, B; Loffler, H; Ludwig, WD; Schoch, C; Haferlach, T; Maschmeyer, G; Staib, P; Aul, C; Heyll, A; Gruneisen, A; Rasche, H; Eimermacher, H; Balleisen, L; Pielken, HJ; Reis, HE; Griesinger, F; Reichle, A; Sauerland, MC; Heinecke, A
      Acute myeloid leukemia in adults: Is postconsolidation maintenance therapynecessary?

      INTERNATIONAL JOURNAL OF HEMATOLOGY
    26. Chowdhary, V; Nityanand, S; Prasad, KN; Pandey, R; Dabadghao, S
      Sweet's syndrome and Pneumocystis carinii pneumonia: two sequelae of low-dose cytosine arabinoside therapy in a patient with acute myeloid leukemia

      EUROPEAN JOURNAL OF HAEMATOLOGY
    27. Lancet, JE; Willman, CL; Bennett, JM
      Acute myelogenous leukemia and aging - Clinical interactions

      HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
    28. Gamis, AS; Howells, WB; DeSwarte-Wallace, J; Feusner, JH; Buckley, JD; Woods, WG
      Alpha hemolytic streptococcal infection during intensive treatment for acute myeloid leukemia: A report from the Children's Cancer Group study CCG-2891

      JOURNAL OF CLINICAL ONCOLOGY
    29. Hofmann, WK; Seipelt, G; Kalina, U; Hoelzer, D
      New aspects of the treatment of patients with low-risk myelodysplastic syndromes

      ONKOLOGIE
    30. Nakamura, Y; Sekine, I; Furuse, K; Saijo, N
      Retrospective comparison of toxicity and efficacy in phase II trials of 3-h infusions of paclitaxel for patients 70 years of age or older and patients under 70 years of age

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    31. Anders, K; Grabenbauer, GG; Schuchardt, U; Fahlbusch, R; Fietkau, R; Sauer, R; Krauseneck, P
      Accelerated radiotherapy with concomitant ACNU/Ara-C for the treatment of malignant glioma

      JOURNAL OF NEURO-ONCOLOGY
    32. Kuhr, T; Eisterer, W; Apfelbeck, U; Linkesch, W; Bechter, O; Zabernigg, A; Geissler, K; Barbieri, G; Duba, C; Gastl, G; Thaler, J
      Treatment of patients with advanced chronic myelogenous leukemia with interferon-alpha-2b and continuous oral cytarabine ocfosfate (YNK01): a pilot study

      LEUKEMIA RESEARCH
    33. Akashi, K; Eto, T; Shibuya, T; Shimoda, K; Harada, M; Niho, Y
      Aclarubicin induces differentiation of leukemic progenitors in myelodysplastic syndrome cooperating with granulocyte colony-stimulating factor

      LEUKEMIA RESEARCH
    34. Cheson, BD; Zwiebel, JA; Dancey, J; Murgo, A
      Novel therapeutic agents for the treatment of myelodysplastic syndromes

      SEMINARS IN ONCOLOGY
    35. Visani, G; Rosti, G; Bandini, G; Tosi, P; Isidori, A; Malagola, M; Stanzani, M; Martinelli, G; Piccaluga, P; Testoni, N; Ricci, P; Tura, S
      Second chronic phase before transplantation is crucial for improving survival of blastic phase chronic myeloid leukaemia

      BRITISH JOURNAL OF HAEMATOLOGY
    36. Lester, WA; Hull, DR; Fegan, CD; Morris, TCM
      Respiratory failure during induction chemotherapy for acute myelomonocyticleukaemia (FAB M4Eo) with Ara-C and all-trans retinoic acid

      BRITISH JOURNAL OF HAEMATOLOGY
    37. Lawson, SE; Harrison, G; Richards, S; Oakhill, A; Stevens, R; Eden, OB; Darbyshire, PJ
      The UK experience in treating relapsed childhood acute lymphoblastic leukaemia: a report on the Medical Research Council UKALLR1 study

      BRITISH JOURNAL OF HAEMATOLOGY
    38. Estey, EH
      How I treat older patients with AML

      BLOOD
    39. Zojer, N; Meran, JG; Vesely, M; Gruner, H; Ackermann, J; Dellinger, C; Zimmer-Roth, I; Heinz, R; Drach, J; Ludwig, H
      Trisomy 13 is associated with poor prognosis in idiopathic myelofibrosis with myeloid metaplasia

      LEUKEMIA & LYMPHOMA
    40. Ha, CS; Chung, WK; Koller, CA; Cox, JD
      Role of radiation therapy to the brain in leukemic patients with cranial nerve palsies in the absence of radiological findings

      LEUKEMIA & LYMPHOMA
    41. Cho, SG; Moon, H; Lee, JH; Lee, SY; Kim, CC; Lee, KS
      Behenoyl cytarabine-associated reversible encephalopathy in a patient withacute myelogenous leukemia

      JOURNAL OF KOREAN MEDICAL SCIENCE
    42. Fridborg, H; Jonsson, E; Nygren, P; Larsson, R
      Relationship between diagnosis-specific activity of cytotoxic drugs in fresh human tumour cells ex vivo and in the clinic

      EUROPEAN JOURNAL OF CANCER
    43. Tanaka, M; Kanamori, H; Yamaji, S; Mishima, A; Fujita, H; Fujisawa, S; Murata, T; Koharazawa, H; Matsuzaki, M; Mohri, H
      Low-dose cytarabine-induced hepatic and renal dysfunction in a patient with myelodysplastic syndrome

      ANTI-CANCER DRUGS
    44. Courtney, MJ; Coffey, ET
      The mechanism of Ara-C-induced apoptosis of differentiating cerebellar granule neurons

      EUROPEAN JOURNAL OF NEUROSCIENCE
    45. Ferrara, F; Melillo, L; Montillo, M; Leoni, F; Pinto, A; Mele, G; Mirto, S
      Fludarabine, cytarabine, and G-CSF (FLAG) for the treatment of acute myeloid leukemia relapsing after autologous stem cell transplantation

      ANNALS OF HEMATOLOGY
    46. Hsu, C; Lin, MT; Tang, JL; Tien, HF; Wang, CH; Chen, YC
      Allogeneic stem cell transplantation for patients with high-risk myelodysplastic syndrome

      JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION
    47. Hellstrom-Lindberg, E
      Treatment of adult myelodysplastic syndromes

      INTERNATIONAL JOURNAL OF HEMATOLOGY
    48. McGrail, LH; Sehn, LH; Weiss, RB; Robson, MR; Antin, JH; Byrd, JC
      Pancreatitis during therapy of acute myeloid leukemia: Cytarabine related?

      ANNALS OF ONCOLOGY
    49. Aleskog, A; Larsson, R; Hoglund, M; Sundstrom, C; Kristensen, J
      Evaluation of purine and pyrimidine analogues in human tumor cells from patients with low-grade lymphoproliferative disorders using the FMCA

      EUROPEAN JOURNAL OF HAEMATOLOGY
    50. Seymour, JF; Juneja, SK; Campbell, LJ; Ellims, PH; Estey, EH; Prince, HM
      Secondary acute myeloid leukemia with inv(16): report of two cases following paclitaxel-containing chemotherapy and review of the role of intensifiedara-C therapy

      LEUKEMIA
    51. Gieseler, F; Bauer, E; Nuessler, V; Clark, M; Valsamas, S
      Molecular effects of topoisomerase II inhibitors in AML cell lines: correlation of apoptosis with topoisomerase II activity but not with DNA damage

      LEUKEMIA
    52. Baudard, M; Beauchamp-Nicoud, A; Delmer, A; Rio, B; Blanc, CM; Zittoun, R; Marie, JP
      Has the prognosis of adult patients with acute myeloid leukemia improved over years? A single institution experience of 784 consecutive patients overa 16-year period

      LEUKEMIA
    53. Vera, P; Rohrlich, P; Stievenart, JL; Elmaleh, M; Duval, M; Bonnin, F; Bok, B; Vilmer, E
      Contribution of single-photon emission computed tomography in the diagnosis and follow-un of CNS toxicity of a cytarabine-containing regimen in pediatric leukemia

      JOURNAL OF CLINICAL ONCOLOGY
    54. Beran, M; Estey, E; O'Brien, S; Cortes, J; Koller, CA; Giles, FJ; Kornblau, S; Andreeff, M; Vey, N; Pierce, SR; Hayes, K; Wong, GC; Keating, M; Kantarjian, H
      Topotecan and cytarabine is an active combination regimen in myelodysplastic syndromes and chronic myelomonocytic leukemia

      JOURNAL OF CLINICAL ONCOLOGY
    55. Zecca, M; Pession, A; Messina, C; Bonetti, F; Favre, C; Prete, A; Cesaro, S; Porta, F; Mazzarino, I; Giorgiani, G; Rondelli, R; Locatelli, F
      Total body irradiation, thiotepa, and cyclophosphamide as a conditioning regimen for children with acute lymphoblastic leukemia in first or second remission undergoing bone marrow transplantation with HLA-identical siblings

      JOURNAL OF CLINICAL ONCOLOGY
    56. Ritchey, AK; Pollock, BH; Lauer, SJ; Andejeski, Y; Buchanan, GR
      Improved survival of children with isolated CNS relapse of acute lymphoblastic leukemia: A Pediatric Oncology Group study

      JOURNAL OF CLINICAL ONCOLOGY
    57. Martino, R; Guardia, R; Altes, A; Sureda, A; Brunet, S; Sierra, J
      Time sequential chemotherapy for primary refractory or relapsed adult acute myeloid leukemia: results of the phase II GEMIA protocol

      HAEMATOLOGICA
    58. Kallage, V; Muller, JE; Zimmermann, M; Beck, JD; Ritter, J; Creutzig, U
      Prognosis, therapy realization and toxicity in nonresponders of study AML-BFM 87

      KLINISCHE PADIATRIE
    59. Verbeek, W; Wormann, B; Koch, P; Aul, C; Hinrichs, HF; Balleisen, L; Rowe, JM; Bennett, J; Haase, D; Fonatsch, C; Heinecke, A; Buchner, T; Hiddemann, W
      Results of a randomized double-blind placebo-controlled trial evaluating sequential high-dose cytosine arabinoside mitoxantrone chemotherapy with or without granulocyte/macrophage-colony-stimulating factor in high-risk myelodysplastic syndromes

      JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
    60. Letendre, L; Noel, P; White, WL; Tefferi, A; Litzow, MR; Li, CY; Schroeder, G
      Treatment of unfavorable myelodysplastic syndrome with all-trans-retinoic acid and subcutaneous Ara C

      LEUKEMIA RESEARCH
    61. Latagliata, R; Petti, MC; Mandelli, F
      Acute myeloid leukemia in the elderly: "per aspera ad astra'?

      LEUKEMIA RESEARCH
    62. Beran, M; Kantarjian, H
      Results of topotecan-based combination therapy in patients with myelodysplastic syndromes and chronic myelomonocytic leukemia

      SEMINARS IN HEMATOLOGY
    63. Itoh, M; Aoyama, T; Yamamura, Y; Nakajima, K; Nakamura, K; Kotaki, H; Matsuyama, T; Saitoh, T; Kami, M; Chiba, S; Hirai, H; Yazaki, Y; Iga, T
      Effects of the rational use of corticosteroids eye drops for the prevention of ocular toxicity in high-dose cytosine arabinoside therapy

      YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN
    64. Heaney, ML; Golde, DV
      Myelodysplasia

      NEW ENGLAND JOURNAL OF MEDICINE
    65. Thomas, DA; Kantarjian, H; Smith, TL; Koller, C; Cortes, J; O'Brien, S; Giles, FJ; Gajewski, J; Pierce, S; Keating, MJ
      Primary refractory and relapsed adult acute lymphoblastic leukemia - Characteristics, treatment results, and prognosis with salvage therapy

      CANCER
    66. Sacchi, S; Kantarjian, HM; O'Brien, S; Cortes, J; Rios, MB; Giles, FJ; Beran, M; Koller, CA; Keating, MJ; Talpaz, M
      Chronic myelogenous leukemia in nonlymphoid blastic phase - Analysis of the results of first salvage therapy with three different treatment approaches for 162 patients

      CANCER
    67. Tallman, MS; Lee, S; Sikic, BI; Paietta, E; Wiernik, PH; Bennett, JM; Rowe, JM
      Mitoxantrone, etoposide, and cytarabine plus cyclosporine for patients with relapsed or refractory acute myeloid leukemia - An Eastern Cooperative Oncology Group Pilot Study

      CANCER
    68. Webb, DKH
      Management of relapsed acute myeloid leukaemia

      BRITISH JOURNAL OF HAEMATOLOGY
    69. Koh, LP; Lim, LC
      Cerebellar toxicity following hyperCVAD regimen for acute lymphoblastic leukaemia

      BRITISH JOURNAL OF HAEMATOLOGY
    70. Advani, R; Saba, HI; Tallman, MS; Rowe, JM; Wiernik, PH; Ramek, J; Dugan, K; Lum, B; Villena, J; Davis, E; Paietta, E; Litchman, M; Sikic, BI; Greenberg, PL
      Treatment of refractory and relapsed acute myelogenous leukemia with combination chemotherapy plus the multidrug resistance modulator PSC833 (Valspodar)

      BLOOD
    71. Chim, CS; Lie, AKW; Liang, R; Todd, D; Kwong, YL; Chan, TK
      Treatment of de novo acute myeloid leukaemia in Hong Kong: a twenty-year experience (1975 to 1996)

      AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE
    72. SOUSA AB; FERNANDES JP; COSTA I; FERREIRA G; NUNES O; RIBEIRO P; NEVES A; CRUZ E; AVEIRO F; RODRIGUES AS; BERNARDO M; CONDUTO A; GONCALVES AJ; MONTEIRO A; SOUSA M; SOARES VH; VEIGA J; GOUVEIA J
      GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR IN POSTREMISSION THERAPY OF ACUTE MYELOID-LEUKEMIA

      HEMATOLOGY AND CELL THERAPY
    73. CHAMBERLAIN MC; KORMANIK PA
      NEOPLASTIC MENINGITIS - A GUIDE TO DIAGNOSIS AND TREATMENT

      CNS drugs
    74. POURTSIDIS AG; BAKA M; STASINOPOULOU A; VARVOUTSI M; PAIDOUSSI C; BOUHOUTSOU D; KOSMIDIS HV
      EFFICACY AND SAFETY OF MITOXANTRONE AND ETOPOSIDE (ME) IN REFRACTORY AND RELAPSED ACUTE NONLYMPHOCYTIC LEUKEMIA

      International journal of pediatric hematology/oncology
    75. Mommsen, J; Nagel, JD; Bode, U
      Clinical pharmacokinetics of mitoxantrone - A review

      INTERNATIONAL JOURNAL OF PEDIATRIC HEMATOLOGY/ONCOLOGY
    76. GILES FJ
      MONOCYTE-MACROPHAGES, GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR, AND PROLONGED SURVIVAL AMONG PATIENTS WITH ACUTE MYELOID-LEUKEMIA AND STEM-CELL TRANSPLANTS

      Clinical infectious diseases
    77. Beran, M; Estey, E; O'Brien, SM; Giles, FJ; Koller, CA; Kornblau, S; Keating, M; Kantarjian, HM
      Results of topotecan single-agent therapy in patients with myelodysplasticsyndromes and chronic myelomonocytic leukemia

      LEUKEMIA & LYMPHOMA
    78. SAGAR TG; GANAPATHY S; DEVARAJAN S
      IMPACT OF HIGH-DOSE CYTOSINE-ARABINOSIDE IN POOR-PROGNOSIS ACUTE LYMPHOBLASTIC-LEUKEMIA - CANCER INSTITUTE EXPERIENCE, CHENNAI, INDIA

      Pediatric hematology and oncology
    79. KERN W; BRAESS J; GROTEMETKE A; KUSE H; FUCHS R; HOSSFELD DK; REICHLE A; WORMANN B; BUCHNER T; HIDDEMANN W
      COMBINATION OF ACLARUBICIN AND ETOPOSIDE FOR THE TREATMENT OF ADVANCED ACUTE MYELOID-LEUKEMIA - RESULTS OF A PROSPECTIVE MULTICENTER PHASE-II TRIAL

      Leukemia
    80. BRAESS J; FREUND M; HANAUSKE A; HEIL G; KAUFMANN C; KERN W; SCHUSSLER M; HIDDEMANN W; SCHLEYER E
      ORAL CYTARABINE OCFOSFATE IN ACUTE MYELOID-LEUKEMIA AND NON-HODGKINS-LYMPHOMA - PHASE I II STUDIES AND PHARMACOKINETICS/

      Leukemia
    81. SCHILLER GJ
      TREATMENT OF RESISTANT DISEASE

      Leukemia
    82. KOC Y; AKPEK G; KANSU E; KARS A; TEKUZMAN G; BALTALI E; GULER N; BARISTA I; GULLU I; OZISIK Y; FIRAT D
      BOLUS AND CONTINUOUS-INFUSION MITOXANTRONE IN NEWLY-DIAGNOSED ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA - RESULTS OF 2 CONSECUTIVE PHASE-II CLINICAL-STUDIES

      Cancer investigation
    83. ESTEY EH
      PROGNOSIS AND THERAPY OF SECONDARY MYELODYSPLASTIC SYNDROMES

      Haematologica
    84. CAZZOLA M; ANDERSON JE; GANSER A; HELLSTROMLINDBERG E
      A PATIENT-ORIENTED APPROACH TO TREATMENT OF MYELODYSPLASTIC SYNDROMES

      Haematologica
    85. Mandelli, F; Petti, MC; Lo Coco, F
      Therapy of acute myeloid leukemia: towards a patient-oriented, risk-adapted approach

      HAEMATOLOGICA
    86. MONTILLO M; MIRTO S; PETTI MC; LATAGLIATA R; MAGRIN S; PINTO A; ZAGONEL V; MELE G; TEDESCHI A; FERRARA F
      FLUDARABINE, CYTARABINE, AND G-CSF (FLAG) FOR THE TREATMENT OF POOR-RISK ACUTE MYELOID-LEUKEMIA

      American journal of hematology
    87. CHAMBERLAIN MC
      LEPTOMENINGEAL METASTASES - A REVIEW OF EVALUATION AND TREATMENT

      Journal of neuro-oncology
    88. SAWADA H; SERINO Y; WAKE A; YAMASAKI Y; IZUMI Y
      DISAPPEARANCE OF AML1-MTG8 TRANSCRIPT BY REVERSE-TRANSCRIPTASE POLYMERASE-CHAIN-REACTION IN A PATIENT IN REMISSION OF ACUTE MYELOID-LEUKEMIA (M2) AFTER LOW-DOSE CYTOSINE-ARABINOSIDE

      Leukemia research
    89. OZKAYNAK MF; AVRAMIS VI; CARCICH S; ORTEGA JA
      PHARMACOLOGY OF CYTARABINE GIVEN AS A CONTINUOUS-INFUSION FOLLOWED BYMITOXANTRONE WITH AND WITHOUT AMSACRINE ETOPOSIDE AS REINDUCTION CHEMOTHERAPY FOR RELAPSED OR REFRACTORY PEDIATRIC ACUTE MYELOID-LEUKEMIA/

      Medical and pediatric oncology
    90. BERAN M; KANTARJIAN H
      TOPOTECAN IN THE TREATMENT OF HEMATOLOGIC MALIGNANCIES

      Seminars in hematology
    91. ZUCKERMAN E; ZUCKERMAN T; DOUER D; QIAN DJ; LEVINE AM
      LIVER DYSFUNCTION IN PATIENTS INFECTED WITH HEPATITIS-C VIRUS UNDERGOING CHEMOTHERAPY FOR HEMATOLOGIC MALIGNANCIES

      Cancer
    92. SANTINI V; FERRINI PR
      DIFFERENTIATION THERAPY OF MYELODYSPLASTIC SYNDROMES - FACT OR FICTION

      British Journal of Haematology
    93. BISHOP JF
      APPROACHES TO INDUCTION THERAPY WITH ADULT ACUTE MYELOID-LEUKEMIA

      Acta haematologica
    94. GEISSLER RG; GANSER A
      MYELODYSPLASTIC SYNDROMES - A GUIDE TO TREATMENT WITH EPOETIN AND COLONY-STIMULATING FACTORS

      Biodrugs
    95. THOMAS X; ARCHIMBAUD E
      MITOXANTRONE IN THE TREATMENT OF ACUTE MYELOGENOUS LEUKEMIA - A REVIEW

      HEMATOLOGY AND CELL THERAPY
    96. KEATING MJ
      LEUKEMIA - A MODEL FOR DRUG DEVELOPMENT

      Clinical cancer research
    97. KANTARJIAN HM; TALPAZ M; OBRIEN S; KURZROCK R; GUTTERMAN J; KEATING MJ; MCCREDIE KB; FREIREICH EJ
      CHRONIC MYELOGENOUS LEUKEMIA - PROGRESS AT THE M.-D.-ANDERSON-CANCER-CENTER OVER THE PAST 2 DECADES AND FUTURE-DIRECTIONS - FIRST FREIREICH,EMIL,J AWARD LECTURE

      Clinical cancer research
    98. GREENBERG PL
      THE ROLE OF HEMATOPOIETIC GROWTH-FACTORS IN THE TREATMENT OF MYELODYSPLASTIC SYNDROMES

      International journal of pediatric hematology/oncology
    99. NAND S; STOCK W
      TREATMENT OF PRIMARY MYELODYSPLASTIC SYNDROMES - LESSONS FROM THE ADULT PATIENT POPULATION

      International journal of pediatric hematology/oncology
    100. WOOLLEY I; CURTIS D; SZER J; FAIRLEY C; VUJOVIC O; UGONI A; SPELMAN D
      HIGH-DOSE CYTOSINE-ARABINOSIDE IS A MAJOR RISK FACTOR FOR THE DEVELOPMENT OF HEPATOSPLENIC CANDIDIASIS IN PATIENTS WITH LEUKEMIA

      Leukemia & lymphoma


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 05/08/20 alle ore 13:09:12